Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
opioid |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
639-36-9
|
| gptkbp:contains_functional_group |
phenol
ketone tertiary amine |
| gptkbp:has_ring_structure |
opioid
|
| gptkbp:hasInChIKey |
YVHWDFRCPXGBHO-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C16H17NO4
|
| gptkbp:hasSMILES |
C1C2CC3=C(C1N(C2)CC4=C3C(=O)C=C(C4)O)O
|
| https://www.w3.org/2000/01/rdf-schema#label |
noroxymorphone
|
| gptkbp:IUPACName |
4,5α-epoxy-3,14-dihydroxymorphinan-6-one
|
| gptkbp:legalStatus |
not approved for medical use
|
| gptkbp:metabolism |
gptkb:oxymorphone
|
| gptkbp:PubChem_CID |
5464096
4576566 CHEMBL2106017 |
| gptkbp:relatedTo |
gptkb:oxymorphone
gptkb:naloxone gptkb:naltrexone |
| gptkbp:routeOfAdministration |
not used clinically
|
| gptkbp:studiedBy |
yes
|
| gptkbp:synonym |
3,14-dihydroxy-4,5-epoxymorphinan-6-one
|
| gptkbp:UNII |
1E3C2686ZK
|
| gptkbp:bfsParent |
gptkb:oxycodone
gptkb:N-allylnoroxymorphone |
| gptkbp:bfsLayer |
7
|